{
    "other_tests": [
        {
            "procedure_name": "Western blot analysis",
            "date": "Not specified",
            "findings": "GH-E32A produced significantly increased amounts of 17.5-kDa GH isoform (55% of total GH protein) compared with wt-GH.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Arginine stimulation test",
            "date": "1982",
            "findings": "Low peak levels of GH during sleep (3.2 ng/ml) and arginine stimulation test (2.4 ng/ml); other hormones were normal.",
            "changes_over_time": "At retesting off GH at age 16.6 yr peak GH levels to arginine and exercise were 5.8 and 2 ng/ml, respectively."
        },
        {
            "procedure_name": "Glucagon stimulation test",
            "date": "Age 21 yr",
            "findings": "Normal peak GH level of 12.3 ng/ml.",
            "changes_over_time": "IGF-I level at age 25 yr was low at 101 ng/ml (normal range 127â€“360 ng/ml; /H110023.1 SDS)."
        },
        {
            "procedure_name": "Cell proliferation assay",
            "date": "Not specified",
            "findings": "Cell proliferation rates of cells expressing GH-E32A or coexpressing wt-GH and GH-E32A were significantly lower than those expressing wt-GH.",
            "changes_over_time": "Lower cell proliferation rates were observed at day 3."
        },
        {
            "procedure_name": "Confocal microscopy analysis",
            "date": "Not specified",
            "findings": "Significantly lower colocalization of GH-E32A with secretory granules compared with wt-GH.",
            "changes_over_time": "Not specified."
        }
    ]
}